New TAILORx Data, Published Today in JAMA Oncology, Add to Strong Evidence Base Reinforcing Unique Ability of Oncotype DX Breast Recurrence Score® Test to Guide Chemotherapy Treatment; Clinical Outcomes in Patients with High Recurrence Score® Results Pres

Media coverage

• Title	New TAILORx Data, Published Today in JAMA Oncology, Add to Strong Evidence Base Reinforcing Unique Ability of Oncotype DX Breast Recurrence Score® Test to Guide Chemotherapy Treatment; Clinical Outcomes in Patients with High Recurrence Score® Results Pres
  Media name/outlet	PR Newswire
  Country/Territory	United States
  Date	30/09/19
  Persons	Joseph Sparano

• Title	New TAILORx Data, Published Today in JAMA Oncology, Add to Strong Evidence Base Reinforcing Unique Ability of Oncotype DX Breast Recurrence Score Test to Guide Chemotherapy Treatment
  Media name/outlet	FirstWord MedTech
  Country/Territory	United States
  Date	30/09/19
  URL	www.firstwordmedtech.com/node/1023197?tsid=1
  Persons	Joseph Sparano